PMID- 35187125 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220501 IS - 2297-055X (Print) IS - 2297-055X (Electronic) IS - 2297-055X (Linking) VI - 9 DP - 2022 TI - Epicardial Adipose Tissue and Postoperative Atrial Fibrillation. PG - 810334 LID - 10.3389/fcvm.2022.810334 [doi] LID - 810334 AB - BACKGROUND: Atrial fibrillation (AF) often occurs after cardiac surgery and is associated with increased risk of stroke and mortality. Prior studies support the important role of inflammation in the pathogenesis of postoperative atrial fibrillation (POAF). It is known that an increased volume and a pro-inflammatory phenotype of epicardial adipose tissue (EAT) are both associated with AF onset in non surgical context. In the present study, we aim to evaluate whether also POAF occurrence may be triggered by an increased production of inflammatory mediators from EAT. METHODS: The study population was composed of 105 patients, with no history of paroxysmal or permanent AF, undergoing elective cardiac surgery. After clinical evaluation, all patients performed an echocardiographic study including the measurement of EAT thickness. Serum samples and EAT biopsies were collected before surgery. Levels of 10 inflammatory cytokines were measured in serum and EAT conditioned media. After surgery, cardiac rhythm was monitored for 7 days. RESULTS: Forty-four patients (41.3%) developed POAF. As regard to cardiovascular therapy, only statin use was significantly lower in POAF patients (65.1% vs. 84.7%; p-0.032). Levels of Monocyte Chemoattractant Protein-1 (MCP-1), in both serum and EAT, were significantly higher in POAF patients (130.1 pg/ml vs. 68.7 pg/ml; p = <0.001; 322.4 pg/ml vs. 153.4 pg/ml; p = 0.028 respectively). EAT levels of IL-6 were significantly increased in POAF patients compared to those in sinus rhythm (SR) (126.3 pg/ml vs. 23 pg/ml; p = <0.005). CONCLUSION: Higher EAT levels of IL-6 and MCP-1 are significantly associated with the occurrence of POAF. Statin therapy seems to play a role in preventing POAF. These results might pave the way for a targeted use of these drugs in the perioperative period. CI - Copyright (c) 2022 Petraglia, Conte, Comentale, Cabaro, Campana, Russo, Amaranto, Bruzzese, Formisano, Pilato, Ferrara, Leosco and Parisi. FAU - Petraglia, Laura AU - Petraglia L AD - Department of Translational Medicine, University of Naples Federico II, Naples, Italy. FAU - Conte, Maddalena AU - Conte M AD - Department of Translational Medicine, University of Naples Federico II, Naples, Italy. AD - Clinica San Michele, Maddaloni, Italy. FAU - Comentale, Giuseppe AU - Comentale G AD - Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy. FAU - Cabaro, Serena AU - Cabaro S AD - Department of Translational Medicine, University of Naples Federico II, Naples, Italy. FAU - Campana, Pasquale AU - Campana P AD - Department of Translational Medicine, University of Naples Federico II, Naples, Italy. FAU - Russo, Carmela AU - Russo C AD - Department of Translational Medicine, University of Naples Federico II, Naples, Italy. FAU - Amaranto, Ilaria AU - Amaranto I AD - Department of Translational Medicine, University of Naples Federico II, Naples, Italy. FAU - Bruzzese, Dario AU - Bruzzese D AD - Department of Public Health, University of Naples Federico II, Naples, Italy. FAU - Formisano, Pietro AU - Formisano P AD - Department of Translational Medicine, University of Naples Federico II, Naples, Italy. FAU - Pilato, Emanuele AU - Pilato E AD - Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy. FAU - Ferrara, Nicola AU - Ferrara N AD - Department of Translational Medicine, University of Naples Federico II, Naples, Italy. FAU - Leosco, Dario AU - Leosco D AD - Department of Translational Medicine, University of Naples Federico II, Naples, Italy. FAU - Parisi, Valentina AU - Parisi V AD - Department of Translational Medicine, University of Naples Federico II, Naples, Italy. LA - eng PT - Journal Article DEP - 20220204 PL - Switzerland TA - Front Cardiovasc Med JT - Frontiers in cardiovascular medicine JID - 101653388 PMC - PMC8854347 OTO - NOTNLM OT - Monocyte Chemoattractant Protein-1 OT - epicardial adipose tissue OT - inflammation OT - interleukin-6 OT - postoperative atrial fibrillation COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer PC declared a shared affiliation, with several of the authors to the handling editor at the time of the review. EDAT- 2022/02/22 06:00 MHDA- 2022/02/22 06:01 PMCR- 2022/01/01 CRDT- 2022/02/21 06:05 PHST- 2021/11/06 00:00 [received] PHST- 2022/01/06 00:00 [accepted] PHST- 2022/02/21 06:05 [entrez] PHST- 2022/02/22 06:00 [pubmed] PHST- 2022/02/22 06:01 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fcvm.2022.810334 [doi] PST - epublish SO - Front Cardiovasc Med. 2022 Feb 4;9:810334. doi: 10.3389/fcvm.2022.810334. eCollection 2022.